Clinical trial hold
Eiger halts hepatitis drug development after liver toxicity, seeks funding for other programs
Anika Sharma
Eiger BioPharmaceuticals has made the decision to discontinue the pursuit of a home for peginterferon lambda, a drug that was ...
Gilead’s Magrolimab Faces Fresh Setback as FDA Issues Partial Clinical Hold
Anika Sharma
One month after Gilead Sciences made public its decision to halt a myelodysplastic syndromes (MDS) program centered around magrolimab, the ...
